The collaboration targets employers looking to mitigate rising costs associated with diabetes, hypertension, and weight management. By embedding Dario’s behaviorally-driven solutions directly into the insurer’s existing ecosystem, the company aims to provide scalable, data-backed interventions for large populations. CEO Erez Raphael noted that the strategy leverages established partner infrastructure to accelerate market entry and drive recurring revenue.
Dario’s platform is designed to produce measurable clinical outcomes, including improvements in A1C levels and blood pressure, which historically lead to fewer hospitalizations. The company currently maintains access to over 116 million covered lives across its network. This expansion aligns with a broader growth model focused on lowering customer acquisition costs through channel-led distribution rather than direct-to-employer sales.

Comments (0)
No comments yet. Be the first!